Author

B. Callewaert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Dhir· 1 shared A. Gerken· 1 shared A. Lepelley· 1 shared A. Niehoff· 1 shared A. R. Godwin· 1 shared B. Bader-Meunier· 1 shared C. Baldock· 1 shared C. Bodemer· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dhir

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transglutaminase mediated asprosin oligomerization allows its tissue storage as fibers

Y. A. Morcos, G. Pryymachuk, S. Luetke, A. Gerken, A. R. Godwin, T. A. Jowitt, N. Piekarek, T. Hoffmann, A. Niehoff, M. Odenthal, U. Drebber, O. Grisk, Y. Ladilov, W. Bloch, B. Callewaert, , G. Sengle

The paper identifies transglutaminase-mediated asprosin oligomerization and extracellular fiber formation in connective tissues, suggesting a new mechanism for tissue storage and regulation of asprosin bioavailability.

bioRxiv · Jan 4, 2022 · PreprintBiochemistry

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

A. Lepelley, E. Della Mina, E. Van Nieuwenhove, L. Waumans, S. Fraitag, G. I. Rice, A. Dhir, M.-L. Fremond, M. P. Rodero, L. Seabra, E. Carter, C. Bodemer, D. Buhas, B. Callewaert, P. de Lonlay, , Y. J. Crow

The paper identifies mutations in ATAD3A causing enhanced type I interferon signaling in patients with neurological and autoimmune features.

bioRxiv · Apr 2, 2021Immunology